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Hsp90 is unique among molecular chaperones. The major-
ity of its known substrates are signal transduction proteins,
and recent work indicates that it uses a novel protein-fold-
ing strategy.
 
Cells are equipped with several classes of structurally unre-
lated molecular chaperones to ensure both the proper fold-
ing of proteins upon synthesis and their refolding under
conditions of denaturing stress. Different chaperones follow
distinct strategies to achieve the general goal of preventing
protein misfolding and aggregation in the highly crowded
cellular environment. For example, the monomeric Hsp70
chaperone proteins promiscuously recognize short hydro-
phobic peptide segments such as those exposed in nascent
polypeptide chains. In contrast, the so-called chaperonins
form oligomeric double ring structures capable of enclosing
entire proteins or protein domains to promote folding in a
sequestered environment. Chaperone proteins often cooper-
ate in folding: a polypeptide that is bound by Hsp70 at an
early stage of folding can be transferred to a chaperonin to
reach its final native state (Hartl, 1996; Bukau et al., 2000).
For certain client polypeptides in the eukaryotic cytosol, an
alternate pathway has been proposed in which binding to
Hsp70 is followed by an interaction with the dimeric chap-
erone protein Hsp90 (Smith et al., 1992; Smith, 1993;
Hutchison et al., 1994). Recent advances in understanding
the structure and function of Hsp90 now indicate that it
uses a protein-folding strategy different from that of either
Hsp70 or the chaperonins. Here, we discuss the distinct bio-
chemical mechanisms by which Hsp90 handles its substrate
polypeptides and the unique biological functions of this cu-
rious protein-folding tool.
Unlike Hsp70, eukaryotic cytosolic Hsp90 does not act
generally in nascent protein folding (Nathan et al., 1997).
Hsp90 is distinguished from other chaperones in that most of
its known substrates are signal transduction proteins, the clas-
sical examples being steroid hormone receptors and signaling
kinases (Picard et al., 1990; Xu and Lindquist, 1993). Be-
cause Hsp90 is essential for maintaining the activity of nu-
merous signaling proteins, it plays a key role in cellular signal
transduction networks. At a molecular level, Hsp90 binds to
substrate proteins, which are in a near native state and thus at
a late stage of folding (Jakob et al., 1995) poised for activation
by ligand binding or interaction with other factors. In fulfill-
ing its role, Hsp90 operates as part of a multichaperone ma-
chinery in the cytosol, which includes Hsp70 as mentioned
above but also peptidyl-prolyl isomerases and other cochaper-
ones (Bose et al., 1996; Freeman et al., 1996). This complex-
ity of function has made Hsp90 more difficult to investigate
than the Hsp70 or chaperonin proteins. For example, Hsp90
has only been established recently as an ATP-dependent
chaperone (Prodromou et al., 1997; Obermann et al., 1998;
Panaretou et al., 1998), and the exact functions of the Hsp90
ATPase activity are still being worked out. In the following
sections, we will first describe the structure and mechanism of
the Hsp90 protein, then focus on its regulation by cochaper-
ones, and finally discuss the biological contribution of Hsp90
to cellular processes including signal transduction, protein
degradation, and morphological evolution.
 
Structure and ATPase cycle of Hsp90
 
The highly conserved Hsp90 chaperone family includes the
eponymous Hsp90 (90 kD heat shock protein) of the eu-
karyotic cytosol, termed variously Hsp90
 
 
 
 and 
 
 
 
 in humans
(corresponding to a major and minor isoform), Hsp86 and
Hsp84 in mice, Hsp83 in 
 
Drosophila
 
, and Hsc82 and
Hsp82 in yeast. Other family members are HtpG in the bac-
terial cytosol, Grp94/gp96 in the endoplasmic reticulum of
eukaryotes, and the recently discovered Hsp75/TRAP1 in
the mitochondrial matrix (Argon and Simen, 1999; Felts et
al., 2000; Thomas and Baneyx, 2000). All of these proteins
share a common structural plan (Fig. 1 A) and are thus ex-
pected to have a similar mechanism of action. Hsp90 is a
constitutive homodimer with its main intersubunit contacts
within the COOH-terminal 190 residues (Nemoto et al.,
 
1995). The highly conserved 25 kD NH
 
2
 
-terminal domain
of Hsp90 is the binding site for ATP and for geldanamycin
(GA),* a representative of the ansamycin drugs, which specif-
ically target Hsp90 (Whitesell et al., 1994). GA inhibits the
Hsp90 ATPase with nanomolar affinity, and crystallography
has shown that the drug occupies the nucleotide-binding
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cleft within the NH
 
2
 
-terminal domain (Fig. 1 B) (Prodro-
mou et al., 1997; Stebbins et al., 1997; Obermann et
al., 1998; Panaretou et al., 1998). A divergent charged se-
quence separates the NH
 
2
 
-terminal domain from a conserved
though structurally flexible 35 kD middle domain and the
12 kD COOH-terminal domain required for dimerization
(Stebbins et al., 1997; Maruya et al., 1999). Both the NH
 
2
 
-
and COOH-terminal domains of Hsp90 have been impli-
cated in binding of substrate polypeptides, and substrate
binding at the NH
 
2
 
-terminal site is affected by nucleotides,
GA, and the adjacent charged sequence of Hsp90 (Young et
al., 1997; Scheibel et al., 1998, 1999).
In vitro, Hsp90 from 
 
Saccharomyces cerevisiae
 
 has a slow
but clearly measurable ATPase activity. The affinity of yeast
Hsp90 for ATP (K
 
D
 
 
 
 
 
 100 
 
 
 
M) is about 10 times poorer
than that of the chaperonins and the catalysis rate compara-
ble to that of Hsp70 without cochaperone or peptide stimu-
lation (
 
 
 
0.5 min
 
 
 
1
 
). Interestingly, recent data indicates that
as for Hsp70 the ATPase activity of Hsp90 is stimulated
markedly to a biologically relevant rate by the binding of a
putative substrate protein (Prodromou, C., and L.H. Pearl,
personal communication). In vivo, Hsp90 that has been
mutated to abolish the ATPase activity cannot substitute for
the essential wild-type protein in yeast (Obermann et al.,
1998; Panaretou et al., 1998). As for the other ATP-depen-
dent chaperones, the ATPase cycle is expected to regulate
the interaction of Hsp90 with substrate polypeptides.
The ATP-binding domain of Hsp90 is structurally related
to a superfamily of homodimeric ATPases, comprising in ad-
 
dition to Hsp90 DNA gyrase and topoisomerase II, the
DNA mismatch repair protein MutL, and the histidine ki-
nases CheA and EnvZ (Bergerat et al., 1997; Dutta and In-
ouye, 2000). It has been suggested that Hsp90 shares the
structural mechanism of these proteins in which ATP bind-
ing induces intersubunit contacts between the nucleotide-
binding domains in the homodimer (shown schematically in
Fig. 2) (Dutta and Inouye, 2000). This dimerization of the
nucleotide-binding domains may be critical for ATP hydro-
lysis to occur. Indeed, in the absence of nucleotide Hsp90
dimers have an extended appearance in the electron micro-
scope with the NH
 
2
 
-terminal ATP-binding domains at either
end but can adopt circular structures in the presence of
ATP (Maruya et al., 1999). Following removal of the
COOH-terminal dimerization domain, transient homodimers
of yeast Hsp90 are observed by cross-linking in the presence
of the nonhydrolyzable analogue 5
 
 
 
-adenylylimidodiphosphate
 
(
 
AMP-PNP), and fluorescence probes attached to the NH
 
2
 
termini of full-length Hsp90 interact most strongly with each
other when AMP-PNP is bound (Prodromou et al., 2000).
Intriguingly, a fraction of ATP bound to intact Hsp90 can-
not be competed by free nucleotide and is committed to hy-
drolysis (Weikl et al., 2000). It is tempting to suggest that
formation of the transient NH
 
2
 
-terminal dimer results in se-
questration of the bound nucleotide.
In the gyrase and MutL proteins, the 
 
 
 
-phosphate of the
bound ATP is coordinated by a flexible “lid” sequence within
the ATP-binding domains (Fig. 1 B), and closing of the lid
exposes a binding face that stabilizes the transient dimer
Figure 1. Structural basis for the interaction of Hsp90 with nucleotides, ansamycin drugs, and TPR domain cochaperones. (A) Domain orga-
nization of Hsp90. Amino acid numbers of domain boundaries for human Hsp90  are marked. See text for references. (B) Crystal structures of 
the Hsp90 NH2-terminal domain complexed with ADP and with the ansamycin drug GA (Prodromou et al., 1997; Stebbins et al., 1997). The 
proposed lid sequence over the nucleotide-binding pocket is indicated. (C) Crystal structures of the Hsp70-binding NH2-terminal TPR domain 
of Hop complexed with the Hsp70 COOH-terminal peptide GPTIEEVD (left) and the Hsp90-binding central TPR domain of Hop complexed 
with the Hsp90 COOH-terminal peptide MEEVD (right). Structures in the bottom panel are rotated 90 C from the top panel. The peptides are 
oriented with the COOH-terminal carboxyl groups at the bottom of the figure (top) and towards the viewer (bottom) (Scheufler et al., 2000).
 
o
n
 
A
p
r
i
l
 
3
0
,
 
2
0
0
8
 
w
w
w
.
j
c
b
.
o
r
g
D
o
w
n
l
o
a
d
e
d
 
f
r
o
m
  
Hsp90: a special protein-folding tool|
 
 Young et al. 269
 
(Dutta and Inouye, 2000). A point mutation in the putative
lid sequence favored ATP-dependent dimerization of Hsp90
and also increased its ATPase rate, consistent with the pro-
posed model (Prodromou et al., 2000). However, other in-
terpretations cannot yet be ruled out, since part of the Hsp90
lid sequence can take on an alternate conformation where a
loop partially blocks the ATP-binding pocket (Stebbins et al.,
1997). This may suggest a more complex mechanism to reg-
ulate ATP binding. Also, in MutL the 
 
 
 
-phosphate of ATP
contacts a lysine residue in a segment of the protein structur-
ally unrelated to Hsp90 (Ban et al., 1999), and there may be
further differences between Hsp90 and the other superfamily
members in details of the ATPase mechanism.
How does the ATPase regulate polypeptide binding by
Hsp90? One possible mechanism is suggested by the nucle-
otide-driven cycle of DNA gyrase. The ATP-bound state of
DNA gyrase forms a “molecular clamp,” which is proposed
to close around a DNA strand, and ATP hydrolysis releases
the DNA after the supercoiling reaction (Berger et al., 1996;
Ban et al., 1999). In analogy, the ATP-bound state of
Hsp90 binds stably to substrate polypeptides, whereas sub-
strate release is achieved through ATP hydrolysis. Isolated
complexes of mammalian Hsp90 bound to a model sub-
strate are dissociated with ATP but not with the nonhydro-
lyzable nucleotide AMP-PNP. Furthermore, point muta-
tions in Hsp90, which reduce the ATP hydrolysis rate but
not ATP binding also reduce the efficiency of ATP-depen-
dent complex dissociation (Young and Hartl, 2000). Over-
all, a mechanism is outlined in which a substrate polypep-
tide is held by the closed internally dimerized ATP-bound
clamp of Hsp90 (Fig. 2). Hydrolysis of bound ATP releases
polypeptide by opening up the Hsp90 dimer or by some
other conformational change.
One interesting question raised by this model is the man-
ner in which substrate proteins are held by Hsp90 in the
ATP state. The extended Hsp90 homodimer was estimated
to be 
 
 
 
28-nm long and 7-nm wide (Maruya et al., 1999)
and in a circular clamp conformation could enclose a central
space perhaps 3–4 nm in diameter. Consistent with this esti-
mate, a homodimerized 92-kD fragment of topoisomerase II
provides a hole between 2.5- and 5.5-nm wide (Berger et al.,
1996). For comparison, the cavity of the bacterial chapero-
nin GroEL, which encapsulates nonnative proteins, is 6.5 by
8.0 nm (Hartl, 1996). Thus, although a space encircled by
the Hsp90 dimer is probably too small for an entire protein
substrate to fit inside, a sizable domain could be accommo-
dated. It is also possible that Hsp90 does not enclose its sub-
strate but rather that a substrate-binding face is optimally ex-
posed by Hsp90 in the ATP clamp state. Evidence for
multiple substrate-binding sites along the length of the
Hsp90 protein has been presented, consistent with either
model (Young et al., 1997; Scheibel et al., 1998), but the
structural features of a substrate recognized by Hsp90 have
not yet been determined. Once the precise substrate-binding
mode of Hsp90 has been established, the larger question of
how it aids in folding can be addressed.
 
Regulatory cochaperones of cytosolic Hsp90
 
Although the bacterial and endoplasmic reticulum forms of
Hsp90 appear to operate independently, Hsp90 in the eu-
karyotic cytosol interacts with a variety of cochaperone pro-
teins that assemble into a multichaperone complex and regu-
late the function of Hsp90 and Hsp70. The largest class of
cochaperones bind to Hsp90 via a modular domain contain-
ing typically three 34 amino acid, helix-turn-helix tetratri-
copeptide repeat (TPR) motifs (Fig. 1 C). These TPR do-
mains are found fused to a series of different functional
domains, for example peptidyl-prolyl isomerase domains
(the cyclophilin Cyp40 and the immunophilins FKBP52
and FKBP51) (Johnson and Toft, 1994) or a protein phos-
phatase (PP5) (Chen et al., 1996). Hsp90-binding TPR do-
mains have also been identified fused to other TPR do-
mains, which recognize Hsp70 and then connect Hsp70 to
Hsp90 (p60/Hop/Sti1) (Chen and Smith, 1998; Johnson et
Figure 2. The substrate-binding 
ATPase cycle of Hsp90 (Chadli et al., 
2000; Prodromou et al., 2000; Young 
and Hartl, 2000). (1) Polypeptide sub-
strate may be transferred from Hsc70 to 
the nucleotide-free state of Hsp90 in-
duced by Hop. (2) Hsp90 in the open 
nucleotide-free state can bind substrate 
polypeptide. (3) ATP binding induces 
dimerization of the NH2-terminal do-
mains of Hsp90 (circles) and permits 
p23 binding; substrate is bound by 
Hsp90 clamp. (4) Hydrolysis of bound 
ATP releases substrate by opening clamp 
or by inducing some other conforma-
tional change.
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al., 1998) or may recruit Hsp90 to the mitochondrial im-
port machinery (Tom34) (Young et al., 1998). The TPR co-
chaperone Cns1 in yeast can suppress cyclophilin defects
and may also connect Hsp90 to Hsp70 (Dolinski et al.,
1998; Marsh et al., 1998). Most recently, the TPR cofactor
CHIP was shown to link Hsp90 with the ubiquitination ap-
paratus, controlling protein degradation by the proteasome
(Connell et al., 2001; see below).
The TPR domain cochaperones compete with each other
for a binding site at the COOH terminus of Hsp90 (Chen
et al., 1998; Young et al., 1998). In the case of the cochaper-
one Hop, the TPR domain containing the main Hsp90-
binding site recognizes the five COOH-terminal residues
MEEVD of Hsp90. The isolated TPR domain binds to the
pentapeptide with specificity and affinity comparable to the
interaction between the full-length proteins. Although this
may seem surprising, the crystal structure of the TPR do-
main bound to a synthetic peptide shows that the stacked
 
 
 
-helices of the TPR motifs form a groove, which makes con-
siderable contacts with the peptide (Fig. 1 C). In particular,
the peptide is anchored by interactions with several con-
served residues in the TPR domain that form a “two-carbox-
ylate clamp” to hold the side chain and carboxyl group of
the terminal aspartate residue in place. Interestingly, Hsc70
is bound by a separate TPR domain of Hop in a similar fash-
ion with the last eight residues of Hsc70 (GPTIEEVD) held
in the groove of the TPR domain and anchored by an iden-
tical carboxylate clamp (Fig. 1 C). Hydrophobic interactions
with the divergent NH
 
2
 
 termini of the peptides account for
the specificity of binding (Scheufler et al., 2000).
The amino acid residues of Hop, which form the carboxy-
late clamp, are absolutely conserved in the TPR domains of
other Hsp90-binding cochaperones but not in functionally
unrelated TPR proteins. Also, the COOH-terminal se-
quences of Hsp90 and Hsc70 are conserved within the eu-
karyotic cytosolic forms of these chaperones (Scheufler et al.,
2000). Because both Hsp90 and Hsc70 share a terminal
EEVD sequence, there should be TPR domains, which can
bind either chaperone at the same site. This has now been
observed with the single TPR domain of the cochaperone
CHIP (Connell et al., 2001; Meacham et al., 2001).
In addition to linking Hsp90 with the Hsc70 chaperone
system, Hop acts as an inhibitor of the Hsp90 ATPase by
preventing access to the nucleotide-binding site of Hsp90.
This inhibitory activity of Hop has been proposed to be part
of a substrate-loading mechanism for Hsp90, where an
Hsp90-Hop-Hsc70 complex permits transfer of substrate
polypeptide from Hsc70 to the nucleotide-free state of
Hsp90 (Prodromou et al., 1999) (Fig. 2). Binding of ATP
onto Hsp90 should then displace the Hop-Hsc70 load-
ing system and simultaneously close the substrate-binding
clamp of Hsp90 (Fig. 2). Although such a loading mecha-
nism remains to be demonstrated directly, it is consistent
with earlier time course experiments, showing that initial
binding of Hsc70, Hop, and Hsp90 to progesterone recep-
tor was followed by the dissociation of Hsc70 and Hop,
leading to “mature” Hsp90 complexes (Smith et al., 1992;
Smith, 1993; Hutchison et al., 1994).
Mature complexes of Hsp90 with bound substrate are also
characterized by binding of the cochaperone p23 (Johnson
 
and Toft, 1994), which is unrelated to the TPR domain pro-
teins. Although p23 can itself act as a chaperone in binding
unfolded polypeptides (Bose et al., 1996; Freeman et al.,
1996), p23 and its yeast homologue Sba1 recognize specifi-
cally the ATP-bound state of Hsp90 (Sullivan et al., 1997;
Fang et al., 1998), implying a more specialized function of
p23 in regulating the Hsp90 ATPase cycle. The binding site
for p23 is located within the NH
 
2
 
-terminal half of Hsp90
and is supported by induced dimerization of Hsp90 (Chadli
et al., 2000). This is consistent with the structural model of
the Hsp90 ATPase cycle discussed above. Although p23 does
not affect the ATPase activity of Hsp90, the cochaperone sig-
nificantly stimulates the ATP hydrolysis-dependent dissocia-
tion of Hsp90–substrate complexes. One possible mechanism
is that p23 more stringently couples the nucleotide state of
Hsp90 with conformational changes throughout the dimer
(Young and Hartl, 2000). The active core domain of p23 has
an immunoglobulin-like fold with several highly conserved
residues exposed in one cluster, forming the probable contact
site for Hsp90 (Weaver et al., 2000). The core domain of p23
is sufficient for its ATP-dependent action on Hsp90 (Young
and Hartl, 2000), whereas the chaperone activity of p23 re-
sides in a separate COOH-terminal domain (Weikl et al.,
1999). The recently reported Hsp90-independent effects of
p23 on steroid hormone receptor signaling (Freeman et al.,
2000) may arise from this chaperone domain.
The cochaperone protein p50/Cdc37 interacts with Hsp90
and certain protein kinases and is proposed to target Hsp90
to kinases that are dependent on the chaperone for matu-
ration (Dai et al., 1996; Stepanova et al., 1996). Cdc37 has
some properties of a chaperone and may itself contribute
to the folding reaction (Kimura et al., 1997). Cdc37 also in-
teracts functionally with androgen receptor but not gluco-
corticoid receptor (Rao et al., 2001). There may be further
cochaperones of Hsp90 yet to be identified. For example,
the proteasome activator PA28 has been reported recently to
stimulate the Hsc70-mediated refolding of luciferase bound
to Hsp90 in vitro (Minami et al., 2000).
 
Hsp90 and signal transduction
 
A growing set of signal transduction proteins constitute the
majority of known Hsp90 substrates. These proteins are
critically dependent on Hsp90 for their maturation and con-
formational maintenance. Disruption of Hsp90 function by
mutations or treatment with inhibitors such as the ansamy-
cins led to multiple physiologic defects in live cells, consis-
tent with a contribution of Hsp90 throughout the cellular
signaling network. For example, in the regulation of cell di-
vision alone disruption of Hsp90 affects multiple stages of
the mitogenic signal cascade, cyclin-dependent progression
through both G1 and G2, and centrosome function during
mitosis (Fisher et al., 2000; for review see Helmbrecht et al.,
2000; Lange et al., 2000).
An in vivo requirement for Hsp90 has been established for
some steroid hormone receptors (Picard et al., 1990; for re-
view see Pratt and Toft, 1997), several tyrosine and serine/
threonine kinases such as pp60/v-src, Wee-1, Cdk4, and Raf
(Xu and Lindquist, 1993; Aligue et al., 1994; Stepanova
et al., 1996; van der Straten et al., 1997), and disparate
proteins such as nitric oxide synthase and calcineurin (Gar-
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cia-Cardena et al., 1998; Imai and Yahara, 2000). These
proteins are characteristically large and multidomain and re-
quire stabilizing interactions with other factors for their
function such as steroid ligands for the steroid hormone re-
ceptors or cyclins for the cyclin-dependent kinases. Because
signaling proteins with multiple regulatory states often un-
dergo a conformational switch, the structural flexibility
needed for these steps may render them inherently less stable
and thus more likely to be recognized by Hsp90. On the
other hand, under stress conditions such as heat shock
Hsp90 contributes more generally to the refolding of dena-
tured proteins (Nathan et al., 1997). Although the exact
structural features recognized by Hsp90 are not yet under-
stood, the exposure of these features to Hsp90 is likely a re-
sult of intrinsic or stress-induced structural flexibility. Thus,
interactions of substrate proteins with Hsp90 arise from
structural properties at the molecular level rather than bio-
logical function.
The best characterized example of an Hsp90-dependent
signaling pathway is that of the steroid hormone receptors
(Pratt and Toft, 1997) (Fig. 3 A). Interaction of the gluco-
corticoid receptor with Hsp90 is essential for its activity (Pi-
card et al., 1990), and the unstable ligand-binding domain
of the receptor is sufficient for this interaction (Young and
Hartl, 2000). Monomeric glucocorticoid receptor and the
closely related progesterone receptor are loaded onto Hsp90
by the Hsp70/Hop-dependent mechanism described above
and attain their hormone-binding conformation after bind-
ing to Hsp90. Once the folded monomeric receptor has
been released from the chaperones, it either binds the appro-
priate steroid hormone, resulting in dimerization and activa-
tion, or remains unstable and is recognized again by the
chaperone machinery (Smith, 1993). Recently, progesterone
receptor and glucocorticoid receptor have been used to re-
constitute the typical multichaperone complexes with puri-
fied mammalian Hsp90, Hsc70, Hop, and p23. Although
the requirement for cochaperones in vitro is still controver-
sial (Morishima et al., 2000; Rajapandi et al., 2000), the
ATP-dependent function of Hsp90 in steroid receptor mat-
uration has been demonstrated (Grenert et al., 1999).
In the case of v-src and other kinases, Hsp90 is thought to
stabilize the exposed catalytic domains before assembly of
the kinases into the final signaling complex, a mechanism
conceptually related to the steroid receptor pathway (Xu and
Lindquist, 1993; Aligue et al., 1994; Stepanova et al., 1996).
A variation of the steroid receptor signaling pathway has
been reported for the 
 
Drosophila
 
 ecdysone receptor, a mem-
ber of the heterodimeric retinoid X receptor family (Fig. 3
B). The isolated receptor together with its partner protein
USP is already capable of binding ecdysone but not DNA,
and the Hsp90 chaperone machinery converts the hormone-
bound receptor to the active DNA-binding state (Arbeitman
and Hogness, 2000). Another mechanism allows human
Hsp90 to regulate its own expression by sequestering the
monomeric inactive form of heat shock transcription factor
(HSF) 1 under nonstress conditions (Fig. 3 C). Misfolded
proteins produced by stress can compete with HSF1 for
binding to Hsp90, liberating the transcription factor for tri-
merization and initiating the heat shock response (Zou et
al., 1998).
 
Hsp90 and protein degradation
 
The hallmark of ansamycin activity in live cells is induced
degradation of Hsp90 substrate proteins by the ubiquitin-
dependent proteasome pathway (Whitesell et al., 1994; Schulte
et al., 1995). Although ansamycins were identified histori-
Figure 3. Different modes of Hsp90 action in signaling pathways. 
(A) Inactive steroid hormone receptors are folded by the Hsp90 ma-
chinery. Folded receptors either are stabilized and activated by hor-
mone binding or remain unstable and are rebound by chaperones 
(Smith, 1993; Pratt and Toft, 1997). (B) Ecdysone receptor with its 
partner USP can bind hormone but requires folding by the Hsp90 ma-
chinery to become active for DNA binding (Arbeitman and Hogness, 
2000). (C) Monomeric HSF1 is sequestered by Hsp90. Under stress 
conditions, misfolded proteins compete for Hsp90, and HSF1 is dis-
placed from Hsp90 and can form the active trimer (Zou et al., 1998).
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cally as tyrosine kinase inhibitors, they are now known to
specifically target Hsp90 family members (Whitesell et al.,
1994). Ansamycins can inhibit the chaperone-mediated fold-
ing of Hsp90 substrates by blocking their ATP-dependent
dissociation from Hsp90 (Schneider et al., 1996; Segnitz and
Gehring, 1997; Stancato et al., 1997; Young and Hartl,
2000). On the other hand, certain substrate proteins are re-
leased from Hsp90 by ansamycins. For these proteins, either
drug-induced degradation is not observed as in the case of
HSF1 (Zou et al., 1998) or the interaction with Hsp90 may
be indirect as in the case of cystic fibrosis transmembrane
regulator (Loo et al., 1998; Meacham et al., 2001).
How are Hsp90-bound polypeptides targeted for degrada-
tion? The TPR cochaperone CHIP, which recognizes both
Hsp90 and Hsc70 (see above), contains a U-box domain ho-
mologous to those of the E4 ubiquitination factors and may
present chaperone-bound misfolded proteins for ubiquiti-
nation. Consistent with this possibility, overexpression of
CHIP in cultured cells caused increased ubiquitination and
degradation of glucocorticoid receptor and cystic fibrosis
transmembrane regulator, known substrates of Hsp90 and
Hsc70, respectively (Connell et al., 2001; Meacham et al.,
2001). In terms of the kinetic model of protein folding and
degradation (Wickner et al., 1999), the activity of CHIP
suggests that substrates, which reside longer on Hsp90, for
example when its ATPase is inhibited by GA, would be
more likely to be ubiquitinated. The existence of CHIP also
suggests that like protein folding, protein targeting to the
degradation machinery is regulated by additional factors
whose functions are not anticipated by a simple kinetic-par-
titioning model.
 
Hsp90 and morphological evolution
 
Defects in cell physiology caused by Hsp90 disruption can
lead to defects at the level of tissue and organism. Interest-
ingly, recent work connects Hsp90 function with morpholog-
ical evolution, a process that often requires the effects of inde-
pendent genetic changes (Rutherford and Lindquist, 1998).
Hsp90-null mutants are lethal in eukaryotes, but surprisingly
partial disruption of Hsp90 in 
 
Drosophila
 
 by a temperature-
sensitive mutation or low amounts of GA shows a wide as-
sortment of heritable phenotypic variations. The variations
may arise from alleles of proteins, which depend on the full
function of Hsp90 as a conformational buffer to maintain
“wild-type” activity but whose phenotypes can be stabilized
by other genes following selection. By extension, polymor-
phisms in all of the proteins participating in an Hsp90-
dependent signaling pathway should be buffered by Hsp90
function. In the wild, overloading of the Hsp90 “capaci-
tor” with denatured proteins under environmental stress
could similarly increase the phenotypic diversity on which nat-
ural selection and ultimately evolution acts (Rutherford and
Lindquist, 1998). Hsp90 with its connection to the cellular
signaling network may be particularly suited to such a func-
tion. Thus, the mechanisms of chaperone-mediated protein
folding at a molecular level can be integrated with cellular
processes and with the development of organisms and species.
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